Stock listing

HKEX:2335 Shaanxi Micot Pharmaceutical Technology Co., Ltd. (麥科醫藥) 股價

Follow Shaanxi Micot Pharmaceutical Technology Co., Ltd. into a list and get an email when it puts out news.

Share price · HKEX:2335

$18.40 HKD -0.60 (-3.2%)

Close on Nov 20, 2026

Past 3 months -50.1% · daily closes, Jun 24, 2026 – Nov 20, 2026, adjusted for splits
Day range
$17.30 – $19.29 HKDNov 20, 2026
Volume
3.02M sharesNov 20, 2026
Market cap
$6.10B HKDAt the close on Nov 20, 2026 · price × 331.7M shares outstanding
Traded on an average day
$58.26M HKDMedian day 606,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2335 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$18.40-0.60-3.2%$18.88$19.29$17.303,021,800
$19.00-1.66-8.0%$21.50$21.62$19.002,779,400
$20.66+0.86+4.3%$19.26$21.30$19.262,812,400
$19.80-0.78-3.8%$20.50$22.82$18.904,568,000
$20.58-1.10-5.1%$21.70$25.30$19.4110,628,600
$21.68+0.36+1.7%$20.80$24.20$20.5010,457,600
$21.32-1.80-7.8%$23.32$23.78$21.183,982,000
$23.12-1.30-5.3%$24.40$25.94$23.087,990,800
$24.42+5.61+29.8%$18.59$24.48$18.3412,704,200
$18.81+2.48+15.2%$16.40$21.32$16.4011,806,200
$16.33+0.41+2.6%$16.17$16.99$15.404,003,800
$15.92-0.08-0.5%$17.20$17.66$14.829,553,400
$16.00+3.99+33.2%$12.05$20.24$12.0226,883,000
$12.01+0.41+3.5%$11.58$12.11$10.801,476,600
$11.60-2.01-14.8%$14.20$14.20$11.412,597,000
$13.61-1.38-9.2%$15.18$16.15$13.455,073,000
$14.99-0.09-0.6%$15.36$16.12$14.623,643,200
$15.08+0.94+6.6%$14.21$18.25$13.6911,213,000
$14.14-0.28-1.9%$14.65$15.45$13.792,311,400
$14.42-0.98-6.4%$15.50$15.50$13.134,440,680
$15.40-0.92-5.6%$16.50$20.60$14.6814,020,400
$16.32-1.22-7.0%$17.97$18.50$15.953,231,200
$17.54-6.46-26.9%$23.00$24.60$17.366,029,800
$24.00+9.37+64.0%$14.63$39.16$14.6314,841,800
$14.63-1.62-10.0%$16.25$16.79$14.00387,800
$16.25-2.79-14.7%$19.88$19.88$15.85282,000
$19.04-2.86-13.1%$21.50$21.68$15.02535,400
$21.90-0.18-0.8%$21.68$22.82$21.58230,400
$22.08-0.56-2.5%$22.58$22.78$21.90327,800
$22.64+0.78+3.6%$21.90$23.06$21.78378,400
$21.86-0.84-3.7%$22.74$22.76$21.40168,800
$22.70+0.76+3.5%$21.98$22.94$21.90240,600
$21.94+0.16+0.7%$21.82$22.28$21.72161,200
$21.78+0.98+4.7%$20.82$22.60$20.80156,400
$20.80+0.14+0.7%$20.50$21.14$20.50270,600
$20.66+0.75+3.8%$19.90$21.18$19.84643,800
$19.91-1.23-5.8%$21.10$21.20$19.87371,800
$21.14-0.80-3.6%$21.90$22.24$20.68265,600
$21.94+0.06+0.3%$21.86$22.30$21.38516,800
$21.88-0.28-1.3%$22.18$22.44$21.60514,000
$22.16-0.30-1.3%$22.50$22.74$22.12569,400
$22.46+0.44+2.0%$22.02$22.66$21.68595,600
$22.02+0.42+1.9%$21.62$22.32$21.60850,200
$21.60+0.58+2.8%$21.06$21.80$20.60654,400
$21.02+0.06+0.3%$21.00$21.74$20.84437,800
$20.96+0.14+0.7%$20.80$21.90$20.68459,800
$20.82-1.16-5.3%$21.94$22.60$20.66634,600
$21.98-2.12-8.8%$24.10$24.10$21.84364,400
$24.10-1.94-7.5%$26.06$26.50$23.84725,600
$26.04-0.06-0.2%$26.08$26.52$25.00617,800
$26.10-0.22-0.8%$26.08$27.10$25.28770,400
$26.32-2.24-7.8%$28.52$28.96$25.461,157,300
$28.56+0.02+0.1%$28.58$28.96$27.98395,600
$28.54+0.14+0.5%$28.40$28.86$27.90380,880
$28.40+0.20+0.7%$28.22$28.72$28.10291,600
$28.20-0.30-1.1%$28.56$28.88$28.10343,600
$28.50-0.30-1.0%$28.78$28.78$26.80322,600
$28.80-0.24-0.8%$29.00$29.18$28.50258,600
$29.04+0.38+1.3%$28.64$29.16$28.60339,200
$28.66+0.24+0.8%$28.40$28.86$28.40279,600
$28.42+0.10+0.4%$28.30$28.76$28.06265,600
$28.32-1.04-3.5%$29.34$29.62$27.80358,600
$29.36-0.84-2.8%$30.18$30.38$29.04306,400
$30.20-0.40-1.3%$30.64$31.40$29.90418,800
Ticker
HKEX:2335
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

All Shaanxi Micot Pharmaceutical Technology Co., Ltd. news

Shaanxi Micot Pharmaceutical Technology Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
15 in the last 12 months · 15 in all · newest Nov 20, 2026 · oldest 2026

Valuation

Price/book 5.5× against a median of 3.4×: 6th lowest of 9 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$4.70B HKD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
5.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H · HKEX:2335US$778.7MUS$600.0Mn/an/an/a5.5×n/a0.0×n/a
Odyssey Therapeutics, Inc. · NASDAQ:ODTXUS$815.2MUS$512.7Mn/an/an/a2.2×n/a0.1×1.11
NATURECELL Co., Ltd. · KRX:007390US$803.4MUS$787.5Mn/a51.4×n/a17.1×−13.2%0.0×n/a
Arbutus Biopharma Corporation · NASDAQ:ABUSUS$796.4MUS$458.9M3.6×2.5×3.1×9.3×121.2%0.0×1.10
Genfleet Therapeutics (Shanghai), Inc. Class H · HKEX:2595US$787.5MUS$519.4Mn/a26.6×n/a3.3×n/a0.0×n/a
Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWDUS$778.1MUS$702.9M5.2×1.8×n/an/a37.4%n/a1.16
Syndax Pharmaceuticals, Inc. · NASDAQ:SNDXUS$772.7MUS$695.6Mn/a2.4×n/an/a−72.4%n/a0.64
MeiraGTx Holdings plc · NASDAQ:MGTXUS$766.4MUS$715.6M9.8×1.8×3.7×3.6×19.5%0.6×1.57
ORIC Pharmaceuticals, Inc. · NASDAQ:ORICUS$764.9MUS$503.6Mn/an/an/a2.3×n/a0.0×1.22
Inventiva SA · EURONEXT:IVAUS$760.9MUS$577.3Mn/a117×n/a11.8×n/a1.1×n/a
Rigel Pharmaceuticals, Inc. · NASDAQ:RIGLUS$754.9MUS$663.4M2.5×2.3×8.3×1.7×106.6%0.0×1.02
Median of the othersUS$775.4MUS$620.4M4.4×2.5×3.7×3.4×28.4%0.0×1.11

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
38.37 HKD · Analysts' mean
EPS, year to Dec 2026
-0.96 · 1 analyst

Financings

RaiseDateIn US dollars
Public offering of h Shares
Update: HK$1.06B · HK$18.2 a share · 瑞邦證券
Dealers: 瑞邦證券 (co-lead)
Buyers: Qiyuan Hong Kong (18,756,200 Offer Shares, 32.31% of Offer Shares, 5.65% of total issued share capital; cornerstone investor and close associate of existing Shareholders); Everest Medicine (5,494,400 H Shares as cornerstone investor); Summit Capital (430,400 H Shares as cornerstone investor)
Jun 23, 2026US$134.75M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CNY

Income statement

LineFY2025FY2024
Revenue00
Research and development130.1M107.0M
Selling, general and administrative7.77M6.22M
Operating income-153.3M-125.1M
Depreciation and amortization6.57M8.39M
EBITDA-146.7M-116.7M
Interest expense67.0M37.6M
Income before tax-184.9M-156.8M
Net income-182.5M-154.6M
Earnings per share, basic-0.55-0.47

Balance sheet

LineFY2025FY2024
Cash and equivalents80.6M64.7M
Short-term investments155.5M115.2M
Current assets262.2M186.0M
Total assets331.5M247.3M
Accounts payable53.7M33.4M
Current liabilities266.4M77.9M
Long-term debt042.3M
Total liabilities1.29B120.5M
Shareholders' equity-972.5M111.8M
Shares outstanding331.7M331.7M

Cash flow

LineFY2025FY2024
Cash from operations-137.1M-107.7M
Capital spending-17.0M-1.30M
Free cash flow-154.1M-109.0M
Change in cash17.5M-31.8M

Open Financials

Filings

FilingDateTypeFiled with
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 20 NOVEMBER 2026Nov 20, 2026Meeting outcomeHKEX
VOLUNTARY ANNOUNCEMENT - ALL ENROLLED PARTICIPANTS COMPLETED PHASE III CLINICAL TRIAL OF MT1013Nov 8, 2026Other filingsHKEX
ANNOUNCEMENT IN RELATION TO THE POSTPONEMENT OF THE EGM AND CHANGE OF BOOK CLOSURE PERIODNov 6, 2026Meeting outcomeHKEX
VOLUNTARY ANNOUNCEMENT - RECEIPT OF THE FIRST INSTALMENT OF PROJECT FUNDING UNDER A NATIONAL MAJOR SCIENCE AND TECHNOLOGY PROJECT AND OBTAINING ETHICS APPROVAL FROM THE LEAD INSTITUTION FOR THE PHASE III CLINICAL TRIAL OF MT200605Nov 4, 2026Other filingsHKEX
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026Nov 3, 2026Monthly returnHKEX
NOTICE OF EXTRAORDINARY GENERAL MEETINGOct 22, 2026Meeting noticeHKEX
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 10 NOVEMBER 2026Oct 22, 2026Proxy formHKEX
PROPOSED GENERAL MANDATE TO REPURCHASE H SHARES AND NOTICE OF EXTRAORDINARY GENERAL MEETINGOct 22, 2026Meeting noticeHKEX
PROPOSED ADOPTION OF THE H SHARE INCENTIVE SCHEME AND PROPOSED GENERAL MANDATE TO REPURCHASE H SHARESOct 15, 2026Other filingsHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 6, 2026Monthly returnHKEX
All 15 filings
FilingDateTypeFiled with
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORMSep 30, 2026Notification letterHKEX
2026 INTERIM REPORTSep 30, 2026Interim reportHKEX
ANNOUNCEMENT OF ALLOTMENT RESULTSJun 23, 2026Offer documentHKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONSJun 22, 2026List of directorsHKEX
Documents on DisplayJun 14, 2026Other filingsHKEX

Open Filings

Cap table

Built by 6ix from Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H’s releases

Common shares
331,740,400
Fully diluted
331,740,400

Fully diluted

LineShares
Common shares331,740,400

Share count over time

CountShares
Nov 22, 2026331,740,400

Open Cap table

Shareholders

HolderSharesOf the companyAs of
Wang Bing44.4M85.9%Jun 24, 2026
Wang Mei44.4M85.9%Jun 24, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Shaanxi Micot Pharmaceutical Technology Co., Ltd.